Gerresheimer AG (ETR:GXI)
53.60
+0.20 (0.37%)
Apr 24, 2025, 5:36 PM CET
Gerresheimer AG Revenue
Gerresheimer AG had revenue of 520.05M EUR in the quarter ending February 28, 2025, with 11.57% growth. This brings the company's revenue in the last twelve months to 2.09B, up 4.55% year-over-year. In the fiscal year ending November 30, 2024, Gerresheimer AG had annual revenue of 2.04B with 2.28% growth.
Revenue (ttm)
2.09B
Revenue Growth
+4.55%
P/S Ratio
0.89
Revenue / Employee
153.30K
Employees
12,142
Market Cap
1.85B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Nov 30, 2024 | 2.04B | 45.42M | 2.28% |
Nov 30, 2023 | 1.99B | 173.39M | 9.54% |
Nov 30, 2022 | 1.82B | 319.09M | 21.30% |
Nov 30, 2021 | 1.50B | 79.22M | 5.58% |
Nov 30, 2020 | 1.42B | 26.53M | 1.91% |
Nov 30, 2019 | Pro | Pro | Pro |
Nov 30, 2018 | Pro | Pro | Pro |
Nov 30, 2017 | Pro | Pro | Pro |
Nov 30, 2016 | Pro | Pro | Pro |
Nov 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Merck KGaA | 21.16B |
Siemens Healthineers AG | 22.67B |
Fresenius SE & Co. KGaA | 21.83B |
Bayer Aktiengesellschaft | 46.61B |
Sartorius Aktiengesellschaft | 3.44B |
Fresenius Medical Care AG | 19.34B |
Carl Zeiss Meditec AG | 2.08B |
Fielmann Group AG | 2.16B |
Gerresheimer AG News
- 10 days ago - EQS-PVR: Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution - Wallstreet:Online
- 13 days ago - Gerresheimer AG (GRRMF) Q1 2025 Earnings Call Highlights: Revenue Surge Amidst Organic Challenges - GuruFocus
- 13 days ago - Gerresheimer AG (GRRMF) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 13 days ago - Gerresheimer Non-GAAP EPS of Є0.46, revenue of Є520.1M; initiates FY25 outlook - Seeking Alpha
- 14 days ago - Gerresheimer's first-quarter results hit by low demand in moulded glass - Reuters
- 14 days ago - Bormioli Pharma Boosts Gerresheimer's Revenue & Earnings Growth - Wallstreet:Online
- 14 days ago - EQS-News: Gerresheimer: Bormioli Pharma boosts revenues and earnings - Wallstreet:Online
- 21 days ago - KKR drops out of consortium seeking Gerresheimer takeover, Bloomberg News reports - Reuters